Search research articles
Contact Us
Filters
Showing results (71-80 of 213) with videos related to
Page
of 22
Sort By:
Frontiers in Surgery
|
November 12, 2019
Very Early Continence After Radical Prostatectomy and Its Influencing Factors
Lena Theissen, Felix Preisser, Mike Wenzel, et al.
European Urology Focus
|
February 21, 2023
Prediction of Significant Prostate Cancer in Equivocal Magnetic Resonance Imaging Lesions: A High-volume International Multicenter Study
August Sigle, Angelika Borkowetz, Jost von Hardenberg, et al.
JCI Insight
|
January 2, 2026
The native human glomerulus features a slit diaphragm resembling a densely interwoven fishnet
Deborah Moser, Alexandra N Birtasu, Lilli Skaer, et al.
Medicina (Kaunas, Lithuania)
|
July 27, 2024
The Association between Patient Characteristics and Biochemical Recurrence after Radical Prostatectomy
Carolin Siech, Mike Wenzel, Carsten Lange, et al.
BJU International
|
January 23, 2026
Diagnostic accuracy and outcomes of lymph node staging in intermediate-risk prostate cancer
Christopher Kniep, Tobias Maurer, Ben Frederik Hartwieg, et al.
The Prostate
|
January 29, 2026
External Validation of the Martini-Klinik Nomogram Predicting the Indication for Adjuvant Radiation Therapy According to EAU Guidelines Among Patients With High-Risk Prostate Cancer After Radical Prostatectomy
Carolin Siech, Tonio Brüggemann, Quynh Chi Le, et al.
Frontiers in Surgery
|
December 27, 2021
Influence of Biopsy Gleason Score on the Risk of Lymph Node Invasion in Patients With Intermediate-Risk Prostate Cancer Undergoing Radical Prostatectomy
Mike Wenzel, Felix Preisser, Benedikt Hoeh, et al.
BMC Cancer
|
March 2, 2026
Cancer-control outcomes of patients with metastatic hormone-sensitive prostate cancer and ≥ 10 bone metastases receiving apalutamide: a real-world cohort
Mike Wenzel, Maximilian Filzmayer, Carolin Siech, et al.
Urologia Internationalis
|
March 6, 2024
Real-World Evidence of Tumor and Patient Characteristics and Survival with Avelumab Maintenance after Chemotherapy for Advanced and Metastatic Urothelial Carcinoma
Séverine Banek, Mike Wenzel, Benedikt Lauer, et al.
The Prostate
|
July 11, 2024
Survival of patients with lymph node versus bone versus visceral metastases according to CHAARTED/LATITUDE criteria in the era of intensified combination therapies for metastatic hormone-sensitive prostate cancer
Mike Wenzel, Nele Wagner, Benedikt Hoeh, et al.
Page
of 22
Search research articles
Search
Showing results (71-80 of 213) with videos related to
Sort By:
Page
of 22
Frontiers in Surgery
|
November 12, 2019
Very Early Continence After Radical Prostatectomy and Its Influencing Factors
Lena Theissen, Felix Preisser, Mike Wenzel, et al.
European Urology Focus
|
February 21, 2023
Prediction of Significant Prostate Cancer in Equivocal Magnetic Resonance Imaging Lesions: A High-volume International Multicenter Study
August Sigle, Angelika Borkowetz, Jost von Hardenberg, et al.
JCI Insight
|
January 2, 2026
The native human glomerulus features a slit diaphragm resembling a densely interwoven fishnet
Deborah Moser, Alexandra N Birtasu, Lilli Skaer, et al.
Medicina (Kaunas, Lithuania)
|
July 27, 2024
The Association between Patient Characteristics and Biochemical Recurrence after Radical Prostatectomy
Carolin Siech, Mike Wenzel, Carsten Lange, et al.
BJU International
|
January 23, 2026
Diagnostic accuracy and outcomes of lymph node staging in intermediate-risk prostate cancer
Christopher Kniep, Tobias Maurer, Ben Frederik Hartwieg, et al.
The Prostate
|
January 29, 2026
External Validation of the Martini-Klinik Nomogram Predicting the Indication for Adjuvant Radiation Therapy According to EAU Guidelines Among Patients With High-Risk Prostate Cancer After Radical Prostatectomy
Carolin Siech, Tonio Brüggemann, Quynh Chi Le, et al.
Frontiers in Surgery
|
December 27, 2021
Influence of Biopsy Gleason Score on the Risk of Lymph Node Invasion in Patients With Intermediate-Risk Prostate Cancer Undergoing Radical Prostatectomy
Mike Wenzel, Felix Preisser, Benedikt Hoeh, et al.
BMC Cancer
|
March 2, 2026
Cancer-control outcomes of patients with metastatic hormone-sensitive prostate cancer and ≥ 10 bone metastases receiving apalutamide: a real-world cohort
Mike Wenzel, Maximilian Filzmayer, Carolin Siech, et al.
Urologia Internationalis
|
March 6, 2024
Real-World Evidence of Tumor and Patient Characteristics and Survival with Avelumab Maintenance after Chemotherapy for Advanced and Metastatic Urothelial Carcinoma
Séverine Banek, Mike Wenzel, Benedikt Lauer, et al.
The Prostate
|
July 11, 2024
Survival of patients with lymph node versus bone versus visceral metastases according to CHAARTED/LATITUDE criteria in the era of intensified combination therapies for metastatic hormone-sensitive prostate cancer
Mike Wenzel, Nele Wagner, Benedikt Hoeh, et al.
Page
of 22